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Background.Naturally occurring substances from the flavanol and anthocyanin family of polyphenols have been proposed to exert
beneficial effects in the course of obesity. We hypothesized that their effects on attenuating obesity-induced dyslipidemia as well
as the associated inflammatory sequelae especially have health-promoting potential. Methods. Male C57BL/6J mice (𝑛 = 52)
received a control low-fat diet (LFD; 10 kcal% fat) for 6 weeks followed by 24 weeks of either LFD (𝑛 = 13) or high-fat diet
(HFD; 45 kcal% fat; 𝑛 = 13) or HFD supplemented with 0.1% w/w of the flavanol compound epicatechin (HFD+E; 𝑛 = 13) or
an anthocyanin-rich bilberry extract (HFD+B; 𝑛 = 13). Energy substrate utilization was determined by indirect calorimetry in a
subset of mice following the dietary switch and at the end of the experiment. Blood samples were collected at baseline and at 3 days
and 4, 12, and 20 weeks after dietary switch and analyzed for systemic lipids and proinflammatory cytokines. Adipose tissue (AT)
histopathology and inflammatory gene expression as well as hepatic lipid content were analyzed after sacrifice. Results.The switch
from a LFD to a HFD lowered the respiratory exchange ratio and increased plasma cholesterol and hepatic lipid content. These
changes were not attenuated by HFD+E or HFD+B. Furthermore, the polyphenol compounds could not prevent HFD-induced
systemic rise of TNF-𝛼 levels. Interestingly, a significant reduction in Tnf gene expression in HFD+Bmice was observed in the AT.
Furthermore, HFD+B, but not HFD+E, significantly prevented the early upregulation of circulating neutrophil chemoattractant
mKC. However, no differences in AT histopathology were observed between the HFD types. Conclusion. Supplementation of
HFD with an anthocyanin-rich bilberry extract but not with the flavanol epicatechin may exert beneficial effects on the systemic
early inflammatory response associated with diet-induced obesity. These systemic effects were transient and not observed after
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1. Introduction
The high incidence of obesity is accompanied by a dramatic
increase in metabolic and cardiovascular disorders [1, 2].
Compelling evidence links these disorders to chronic meta-
bolic inflammation [3, 4].The adipose tissue (AT) and in par-
ticular its dysfunction associated with obesity are an impor-
tant contributing factor to this type of systemic inflammation
[5, 6].
Theprimary role of theAT is to store energy in the formof
lipids (triglycerides) for later usage during nutrient depriva-
tion. By storing excess lipids the adipocyte expands, thereby
releasing anorexic signals to inhibit energy intake [7]. How-
ever, when overconsumption persists, the maximum lipid
storage capacity of adipocytes is reached and lipids can no
longer be cleared from the circulation, resulting in elevated
systemic lipid levels (hyperlipidemia) [8]. In parallel, exces-
sive adiposity also triggers the production of proinflamma-
tory cytokines by adipocytes [9], leading to recruitment of
leukocytes to the AT [10].
In a normal inflammatory response, inflammation
resolves once the inflammatory trigger has been eliminated.
However, in the case of obesity-associated inflammation,
the inflammatory triggers in the AT persist, and enhanced
recruitment of leukocytes to the AT is observed [11].
With increasing numbers of infiltrating leukocytes, locally
produced cytokines may be released into the circulation,
thereby contributing to a state of chronic systemic low-
grade inflammation (LGI), frequently observed in obese
patients [12]. LGI may then promote endothelial activation
and leukocyte adhesion in different vascular beds of the
body, thereby driving the development of various vascular
disorders in the periphery like sclerosis in the aorta or kidney.
Thus, as inflammation in the AT plays a pivotal role
in the onset of many obesity-associated metabolic and vas-
cular diseases, attenuating obesity-induced disturbed lipid
metabolism and/or the consequent AT inflammation may
alleviate or even prevent occurrence of obesity-related
pathologies.
In the context of disease prevention, the potential benefi-
cial effects of naturally occurring substances like polyphenols
on lipid metabolism and/or consequent inflammation have
gained particular interest. Polyphenol compounds belonging
to the anthocyanin and flavanol subclasses [13] especially are
thought to exert beneficial effects. Anthocyanins have been
shown to have various health-promoting lipid-modulating
and anti-inflammatory effects [14]. For example, these com-
pounds have been shown to lower plasma cholesterol levels
[15], exhibit anti-inflammatory properties [16, 17], or improve
adipocyte function [18]. Similarly, flavanol species, especially
the catechins, have been shown to exert anti-inflammatory
and antioxidative effects in vivo [19, 20].
We hypothesized that supplementation of high-fat diets
with epicatechin or anthocyanins may have a dual effect
in the prevention of metabolic disorders: it may attenuate
dyslipidemia and/or obesity-associated inflammation. To
address this hypothesis, C57BL/6J mice were fed a high-fat
diet (HFD) or a HFD supplemented with epicatechin or a
bilberry extract, at established doses [21, 22], for 24 weeks
and monitored for lipid metabolism and parameters of local
(adipose tissue) and systemic inflammation.
2. Materials and Methods
2.1. Animal Experiments. C57BL/6J male mice (Charles
River, JAX Laboratories, France) were purchased at the age
of 6 weeks and randomly divided over four groups. Mice
were individually housed in a temperature-controlled room
under a 12 h light-dark cycle with ad libitum access to
water and food. All groups received a control LFD (10 kcal%
fat) (Research Diets Inc., NJ, USA) for 6 weeks. Hereafter
(𝑡 = 0) three groups of mice were switched to either a
HFD (45 kcal% fat) or HFD supplemented with 0.1% w/w
of epicatechin (ChromaDex Inc., Irvine, USA) referred to as
the HFD+E group or 0.1% w/w of the standardized bilberry
(Vaccinium myrtillus L.) extract Mirtoselect which contains
36%of anthocyanins (Mirtoselect, Indena SAS, Paris, France)
referred to as the HFD+B group. Data on diet-induced
obesity (DIO) were compared to age-matched LFD controls.
All HFD types were manufactured at Research Diets Inc.
A schematic representation of the experimental design is
provided as Supplementary Figure 1 in SupplementaryMate-
rial available online at http://dx.doi.org/10.1155/2016/2042107.
Food intake was monitored between 7-8 and 15-16 and 23-24
weeks, averaged for daily intake (g), and corrected for caloric
intake (Supplementary Figure 2).
All experimental procedures were performed with
approval of the University of Groningen Ethics Committee
for Animal Experiments (DEC 6141B), in accordance with
the Dutch law on animal experimentation.
Reference data on the LFD and HFD phenotype, namely,
bodyweight, hepatic lipid, AT histopathology, and inflamma-
tion (Figure 5), were published previously but are included
here as well to illustrate the effects of DIO and as control for
the HFD+E and HFD+B groups [23].
2.2. Blood Collection. Blood samples were obtained from
mice after 6 h fasting (8 am–2 pm) by puncturing the
saphenous vein of the left hind leg. Samples were collected
in EDTA-coated capillary tubes (Microvette 300 KC, Sarstedt
BV, Etten-Leur, Netherlands) and directly put on ice. Samples
were spun down at 3000 rpm, and plasma was aspirated and
stored at −80∘C. Serial blood samples were collected 2 weeks
prior to (baseline) and 3 days and 4, 12, and 20 weeks after
dietary switch from the same mice.
2.3. Serial Plasma Lipid and Cytokine Analyses. Plasma
cholesterol, triglycerides, and free fatty acid (FFA) levels were
determined by commercially available kits, according to the
manufacturer’s instructions (cholesterol: Cholesterol CHOD-
PAP, Roche, Woerden, Netherlands; triglycerides: Hitachi,
Roche, Woerden, Netherlands; FFA: Diagnostic Systems,
Holzheim, Germany).
Plasma TNF-𝛼, mouse KC (mKC; CXCL1), IFN-𝛾, and
IL-6 levels were measured using a Meso Scale Discovery
(Gaithersburg, USA) 10-PlexMULTI-SPOTMouse Cytokine
Assay for plasma, according to the manufacturer’s instruc-
tions. Plasma concentrations of IL-1𝛽, IL-5, and IL-12p70
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were under the detection limit of the assay. Plasma serum
amyloid A (SAA) was measured by ELISA (Tridelta, May-
nooth, Ireland) according to the manufacturer’s instructions.
2.4. Metabolic Analyses In Vivo. Subgroups of mice (𝑛 = 6–
8/group) were placed individually in indirect calorimetric
cages (LabMaster TSE Systems, Bad Homburg, Germany)
from 3 days prior to till 3 days after the dietary switch (6
days; short-term effect) and after 23 weeks (4 days; long-
term effect). Following an initial 24 h acclimatization period,
mice were monitored every 13 minutes for the duration of





) was used to estimate the relative contribution
of fat and carbohydrates to whole-body energy metabolism
in mice. In addition, physical activity and food intake were
closely monitored for the duration of the measurements.
2.5. Sacrifice Procedure and Organ Processing. After 24 weeks
mice were anesthetized (2% isoflurane in O
2
) and whole
blood samples were collected by cardiac puncture for EDTA
plasma isolation. Three visceral adipose depots (gonadal,
mesenteric, and perirenal) were isolated, weighed, partly
snap-frozen in liquid nitrogen, and partly fixed in 10%
formalin. Frozen samples were stored at −80∘C, and formalin
fixed samples were processed as described previously and
embedded in paraffin [24]. Livers were dissected as a whole,
weighed, and then partially stored in paraffin and partially
snap-frozen in liquid nitrogen. Approximately 300mg of the
liver was snap-frozen for assessing liver lipid content.
2.6. Adipose Tissue Histopathological Assessment. Four 𝜇m
thin paraffin sections were stained by hematoxylin and
eosin according to procedures described previously [24].
Quantification of the number of crown-like structures (CLS)
was performed as described previously [23].
2.7. Adipose Tissue Gene Expression Analyses. Total RNA
was isolated from approximately 300mg of adipose tissue
from the gonadal AT depot using RNeasy Lipid Tissue Mini
Kit (Qiagen, Westburg, Leusden, Netherlands) according to
the manufacturer’s instructions. Procedures for subsequent
cDNA synthesis, primer sequences, and RT-qPCR analyses
can be found elsewhere [23].
2.8. Liver Lipids and TG-Profiling. Approximately 300mg of
snap-frozen liver was homogenized, and total intrahepatic
lipids were extracted according to the Bligh andDyermethod
[25]. Intrahepatic free cholesterol (FC) and total cholesterol
(TC) were quantified using commercially available kits (FC:
DiaSys Diagnostic Systems GmbH, Holzheim, Germany;
TC: Roche). Besides hepatic TG quantification (Hitachi,
Roche, Netherlands), liver homogenates were also analyzed
by gas chromatography after transmethylation to determine
specific hepatic fatty acid composition. Specific procedures
are described elsewhere [26].
2.9. Statistical Analyses. Differences between the experimen-
tal groups at one time point were analyzed by a nonparamet-
ric ANOVA with Dunn’s post hoc test comparing all groups
with HFD. Analyses were performed in GraphPad (version
5.00 forWindows, GraphPad Software, SanDiego, CA,USA).
Data are expressed as means ± SEM.The level of significance
was set at 𝑝 < 0.05.
3. Results
3.1. Polyphenols Do Not Alter Diet-Induced Obesity/Adiposity.
Time-course analysis of body weight showed a gradual
increase in bodyweight in all experimental groups.HFDmice
had a significantly higher body weight already at 3 days after
the dietary switch and all subsequent time points thereafter
(Figure 1(a)). The body weights at sacrifice of the HFD+E
and HFD+B mice did not significantly differ from HFD
mice (Figure 1(b)). At sacrifice weights of the visceral adipose
depot (total of gonadal, mesenteric, and perirenal depot
weights) and liver were significantly elevated in HFD mice,
but no significant differences were observed in the HFD+E
andHFD+Bgroups compared toHFDalone (Figures 1(c) and
1(d)).
3.2. Polyphenols Do Not Affect HFD-Induced Changes in
Metabolite Utilization. The respiratory exchange ratio (RER)
was calculated from indirect calorimetric data obtained at
the time of dietary switch and at the end of the experiment.
Switching to a HFD resulted in an immediate decline of the
RER (Figure 2(a)) and remained lowered at the end of the
experiment (Figure 2(b)), suggesting that fat was utilized as
the main energy substrate. Short-term as well as long-term
polyphenol supplementation did not affect RER compared to
HFD.Notably, switching diets did also not alter intake of food
pellet or physical activity in any of the experimental groups
(data not shown).
3.3. Polyphenols Do Not Ameliorate Obesity-Induced Changes
in Lipid Metabolism. Plasma cholesterol levels increased in
serially collected samples of all groups. HFD-feeding led to
elevated cholesterol levels already after 3 days after the dietary
switch and remained significantly elevated throughout the
duration of the experiment. Cholesterol levels in the HFD+E
and HFD+B groups did not significantly differ from the
HFD group (Figure 3(a)). Similarly, plasma triglyceride and
FFA levels did not show differences between the experi-
mental groups and the HFD group (Figures 3(b) and 3(c)).
Additional analysis on intrahepatic lipids levels, as assessed
in liver homogenates after 24w, showed enhanced levels of
total and free cholesterol (Figures 3(d) and 3(e)) and hepatic
triglycerides (Figure 3(f)) in response to HFD. Comparable
intrahepatic lipid levels were observed between HFD and
the groups supplemented with polyphenols. Notably, further
characterization of hepatic TGs did not show a significant
effect of polyphenol supplementation on any of the TG
species that were assessed (Supplementary Table 1).
3.4. Polyphenols Do Not Prevent Obesity-Induced Systemic
Inflammation. Serial plasma cytokine analyses demonstrated
elevated levels of the proinflammatory cytokine TNF-𝛼
shortly after switching to a HFD. This difference reached
statistical significance after 20 weeks of HFD-feeding com-
pared to LFD. No differences were observed when comparing
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Figure 1: Body and organ weights. Polyphenol supplementation does not attenuate HFD-induced obesity (baseline 22.95 ± 0.18) (a-b), total
weight of visceral adipose depot (c), or total liver weight. Dotted line depicts baseline value. Significant (𝑝 < 0.05) from HFD (∗∗𝑝 < 0.01,
∗∗∗
𝑝 < 0.001).
HFD+E and HFD+B with HFD (Figure 4(a)). For mKC, a
neutrophil chemoattractant in mice, an early increase was
observed in HFD mice as well, which was significantly
different at 4 weeks (Figure 4(b)). No differences in the
HFD+E group were observed. Interestingly, mKC levels in
HFD+B treated mice were similar to LFD after the dietary
switch and significantly lower compared to HFD at 4 weeks.
After 12 weeks mKC levels increased and levels became
comparable with those of HFD controls, indicating that
anthocyanin treatment retarded mKC induction. For IL-6,
IFN-𝛾, IL-10, and SAA no significant differences between any
of the groupswere observed (Supplementary Figures 3A–3D).
Plasma levels of IL-5, IL-1𝛽, IL-12p70, and IL-4 were below
the detection limit of the assay.
3.5. Polyphenols Do Not Attenuate Histopathological Fea-
tures or Inflammatory Gene Expression in AT. Histological
assessment of the visceral (gonadal) AT depot (Figure 5(a))
showed increased numbers of crown-like structures (CLS;
Figure 5(b)) in all HFD groups. Neither HFD+E nor HFD+B
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Figure 3: Systemic and hepatic lipids. Serial plasma (a) cholesterol (2.23 ± 0.04 at baseline), (b) triglycerides (0.34 ± 0.04 at baseline), and
(c) free fatty acids (0.84 ± 0.06 at baseline), as well as hepatic (d) free cholesterol, (e) total cholesterol, and (f) triglyceride content, are not
affected by polyphenol supplementation. Dotted lines depict baseline values. Significant from HFD (∗𝑝 < 0.05, ∗∗𝑝 < 0.01).














































Figure 4: Systemic proinflammatory mediators. (a) Polyphenols do not prevent the HFD-induced increase in levels of TNF-𝛼 as measured
in serial plasma samples (10.50 ± 0.29 at baseline). (b) Plasma levels of the neutrophil chemoattractant mKC are suppressed in the HFD+B
group until 4 w but increase thereafter (49.00 ± 3.63 at baseline). Dotted lines depict baseline values. Significant from HFD (∗𝑝 < 0.05).
differed significantly from HFD in number of CLS. The
CLS data were in line with gene expression analyses of
the macrophage marker F4/80 (Figure 5(c)) and monocyte
chemoattractant factor MCP-1 (Figure 5(d)). mRNA expres-
sion of IL-1𝛽was not affected by any of the experimental diets
(Figure 5(e)). Interestingly, mRNA expression of TNF-𝛼 was
4-fold higher in HFD mice compared with LFD but only 2-
3-fold higher in HFD+E and HFD+B mice when compared
to LFD mice (Figure 5(f)). Moreover, TNF-𝛼 expression was
significantly lower in HFD+B mice compared to HFD.
4. Discussion
Here we investigated the potential beneficial effects of
anthocyanin and flavanol compounds on lipid metabolism
(intrahepatic and systemic) and local (adipose tissue) and
systemic inflammation in the context of diet-induced obesity.
Though these compounds are assumed to have beneficial
effects on the course of obesity-associated disorders, in
vivo evidence on their effectiveness is inconsistent [27, 28].
Our current study does not show effects on circulating
lipids or metabolic parameters. However, treatment with
a polyphenol-rich bilberry extract resulted in a significant
reduction of mKC early in time.This effect was transient and
lost at the later time points. Interestingly, HFD+B persistently
lowered the gene expression of TNF-𝛼 in theAT indicating an
anti-inflammatory effect that persisted.
Various studies have shown the antiobesity effect of
compounds from the anthocyanin and catechin subclasses of
polyphenols in vivo [29, 30].This adiposity-modulating effect
could have multiple origins. First, polyphenol substances
could positively affect the uptake of lipid species from the
intestine by manipulation of the microbiota composition
[31]. Furthermore polyphenols have been shown to enhance
𝛽-oxidation in the liver, increasing the utilization of fatty
acids as an energy source [30]. In the AT polyphenols
have been shown to inhibit adipocyte proliferation and TG
synthesis while stimulating lipolysis, resulting in a reduction
in adipocyte size and number [32]. Collectively, these mech-
anisms could contribute to a lowering of local and systemic
lipid levels thereby preventing ectopic lipotoxicity. In our
study we did not observe effects of polyphenols on adiposity,
substrate utilization (respiratory exchange ratio), or hepatic
lipid quantity and composition. The absence of an effect on
plasma lipids is consistent with a recent study in which a
bilberry extract and specific polyphenols (e.g., epicatechin)
were analyzed for potential lipid-modulating effects in a
well-established model of human dysbetalipoproteinemia,
ApoE∗3-Leiden mice [21, 22].
Besides lipid-modulating effects (which may indirectly
prevent metabolic inflammation by alleviating metabolic
overload), polyphenols have also been postulated to have
direct anti-inflammatory effects. Both anthocyanin and cat-
echin species have been shown to prevent inflammation
by inhibiting NF𝜅B activity [21, 33], a master regulator of
inflammatory gene expression. Here we show that HFD-
induced obesity gradually enhanced systemic TNF-𝛼 levels
over a period of 20 weeks and found that supplementation
of the HFD with the polyphenol compounds did not affect
systemic TNF-𝛼 levels. However, Tnf mRNA expression






































































































































































Figure 5: Adipose tissue inflammation at sacrifice. (a) Representative histological pictures of the visceral (gonadal) adipose tissue from
different groups demonstrating an increase in the number of crown-like structures uponHFD-feeding which is not attenuated by polyphenols
supplementation. (b) Quantification of crown-like structures (c) F4/80 and (d) MCP-1 gene expression confirm this phenotype. Expression
of the IL-1𝛽 gene is not affected (e) in contrast to Tnf (f) which is significantly lower in the HFD+B group compared to HFD. Significant from
HFD (∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001).
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in the AT was markedly reduced (by approximately 50%)
in the HFD+E and HFD+B groups compared to that in
HFD (although statistical significance was only reached in
the HFD+B group), indicating that the compounds have
local anti-inflammatory effects at tissue level in the AT.
It is thus possible that the tissue concentrations of the
employed polyphenols (and theirmetabolites) are sufficiently
high to quench inflammation but that the plasma TNF-𝛼
concentrations are not determined by AT, at least under the
conditions employed. In line with this notion, we observed
no effect on the plasma concentrations of proinflamma-
tory cytokines upon surgical removal of inflamed AT in
HFD-treated C57BL/6 mice under comparable conditions as
herein [5] and human studies that investigated the release
of cytokines by AT excluded visceral fat as a significant
source of proinflammatory mediators including TNF-𝛼 [34].
The absence of an effect on TNF-𝛼 plasma levels suggests
that other sources of TNF-𝛼 (e.g., immune cells) are not
quenched by the polyphenol treatments. The liver as a
potential source of inflammation can be excluded under the
conditions employed. As we have shown previously, overt
hepatic inflammation does not occur until 40 weeks of HFD-
feeding in this specific mouse model of DIO [23] and is
therefore unlikely to have contributed to circulating TNF-𝛼
levels.
While infiltrating macrophages are considered the main
contributors to chronic AT dysfunction, neutrophils may
also play an important role, particularly during the initial
onset of the inflammatory response [35]. Therefore, inhibit-
ing neutrophil infiltration could be beneficial in the initial
course of obesity. Recent studies have shown that bilberry
extract markedly reduced hepatic neutrophil infiltration
in nonalcoholic steatohepatitis (NASH) [22] and catechins
have been shown to reduce the inflammatory potential of
neutrophils in obesity [36]. We observed that HFD-feeding
was associated with a significant elevation in plasma levels
of the neutrophil chemoattractant mKC within the first 4
weeks after the dietary switch. Interestingly, we found that
bilberry extract, but not epicatechin, significantly attenuated
this early increase. After 12 weeks however, mKC levels in
the HFD+B group were similar to those in HFD and HFD+E
fedmice, suggesting that short-termmetabolic inflammatory
responses can be quenched by bilberry extract but that these
dietary components are not powerful enough to reduce a
long-term metabolic stress from HFD. Though not assessed
in this study, the early attenuating effect on mKC may have
led to lower numbers of neutrophils. This may potentially
explain the reduced AT inflammation (i.e., reduced Tnf
mRNA expression) after 24 weeks as it may have delayed the
recruitment of macrophages.
A potential explanation for the discrepancy between the
positive health effects of polyphenols reported by others and
the present study may be the higher dosages applied in such
studies [37, 38]. As higher intake results in higher plasma
levels of polyphenolmetabolites, effects are likely to be greater
as well although such pharmacological dosages may also be
constrained by the occurrence of negative side effects [39,
40]. Herein, we notably aimed to investigate the effects of
polyphenols at a moderate dose that can be translated to
the situation in humans. Differences in experimental diets
used may also explain observed differences in efficacy. For
instance, it should be noted that an unhealthy obesogenic
human diet not only contains high levels of dietary fat, as
was studied here, but often contains high levels of cholesterol
as well. As already small quantities of dietary cholesterol
mixed with HFD can have pronounced inflammatory effects
compared with HFD alone [41] and since dietary cholesterol
may affect organs different than those that dietary fat does, it
can be postulated that polyphenols may have different effects
on HFD-induced inflammation when compared to high-
cholesterol diet- (HCD-) induced inflammation. Therefore,
future studies that simultaneously examine HFD- and HCD-
induced inflammation and the effects of polyphenol supple-
mentation thereupon could shed light on this topic.
There is a rapidly growing body of literature on putative
beneficial effects of polyphenols in obesity and associated
disorders. These studies hardly investigate long-term effects
of polyphenols, and they often use relatively high (supra-
physiological) dietary polyphenol concentrations in combi-
nation with experimental diets that are difficult to translate
to humans. In the present long-term intervention study
with (−)-epicatechin or an anthocyanin-rich bilberry extract
(employed at translational doses) we found no effects on
plasma lipids and effects on obesity-associated inflammation.
Anti-inflammatory effects were either transient (e.g., mKC)
or tissue-specific (e.g., TNF-𝛼 in AT) and these tissue-specific
effects were not reflected in plasma. In conclusion, long-term
dietary supplementation with polyphenols attenuates specific
aspects of diet-induced metabolic stress. The assessment of
these effects however requires an analysis on tissue level.
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